Sunday, August 10, 2025

Creating liberating content

A smartphone with a displayed AMD logo is placed on

BENGALURU: A clutch of India-origin AI startups secured significant early-stage

NEW DELHI: Stellantis, one of the world’s top carmakers, will

Bharat Forge, heavily reliant on the US auto sector, faces

Related News

A smartphone with a displayed AMD logo is placed on a computer motherboard in this illustration taken March 6, 2023. Florence Lo | Reuters Nvidia and Advanced Micro Devices have

BENGALURU: A clutch of India-origin AI startups secured significant early-stage funding, attracting marquee global investors. With a global-first approach, these homegrown startups demonstrated early monetisation potential and commanded premium valuations,

NEW DELHI: Stellantis, one of the world’s top carmakers, will launch new petrol and electric cars in India, but does not plan to make investments under govt’s revised EV incentive

Bharat Forge, heavily reliant on the US auto sector, faces potential headwinds from new import duties. Vice-Chairman Amit Kalyani acknowledges possible near-term demand issues but remains optimistic about resolving the

NEW DELHI: India must adopt a comprehensive and forward-looking competitiveness agenda, and undertake factor market reforms such as land reforms, to help realise the goal of emerging as a global

Gokaldas Exports is among the largest players in the garments business, supplying goods to top global markets. The company’s managing director Siva Ganapathi speaks to TOI over the impact and

Trending News

JSW Cement, the building materials arm of Sajjan Jindal-led JSW Group, has reduced the size of its upcoming initial public offering (IPO) to Rs 3,600 crore and will open the

The agricultural Gross Value Added (GVA) growth is expected to moderate to 4.5% in the first quarter of FY26, down from 5.4% in the preceding quarter, according to a report

Foreign portfolio investors (FPIs) turned net sellers in the Indian equity market in July, pulling out Rs 17,741 crore amid rising global trade tensions. According to data from NSDL, this

Avenue Capital Group-backed Asset Reconstruction Company (India) Ltd (ARCIL) has filed its draft red herring prospectus (DRHP) with markets regulator Sebi on Friday to raise funds through an initial public

Russia-backed Nayara Energy looks at India’s state-run oil companies to offload petrol, diesel exports Nayara Energy has approached Indian state-run oil marketing companies (OMCs) to offload its export volumes of

US President Donald Trump on Saturday claimed that he had “heard” reports of India halting Russian oil imports, hailing it as a “good step”. “I understand that India is no

‘Once-A-Week Shot’ Weight-Loss Drug Mounjaro Launched In India By Eli Lilly

Word Count: 337 | Estimated Reading Time: 2 minutes




New Delhi:

Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the country after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO).

The company said it has introduced Mounjaro in a single-dose vial presentation following the marketing authorisation from the CDSCO.

It is a first-of-its-kind treatment for obesity, overweight, and type 2 diabetes that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors.

Mounjaro is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.

It is also indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

“The dual burden of obesity and type 2 diabetes is rapidly emerging as a major public health challenge in India. Lilly is committed to collaborating with the government and industry to promote awareness and improve the prevention and management of these diseases,” Eli Lilly India President and General Manager Winselow Tucker said.

The company’s mission is to make life better for people living with obesity and diabetes in India, he added.

India has about 101 million people living with diabetes and nearly half of these in the adult patients category are being inadequately treated with suboptimal glycemic control.

Obesity, a chronic relapsing disease, is a major risk factor for diabetes and is linked to over 200 health complications, including hypertension, dyslipidemia, coronary heart disease, and obstructive sleep apnea.

As of 2023, adult obesity prevalence in India stood at around 6.5 per cent, affecting nearly 100 million people.

Once-a-weekly, prescription-based medicine, Mounjaro is a single molecule that selectively binds to and activates both GIP and GLP-1 receptors, which are natural incretin hormones.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)




Source link

Most Popular Articles

Sign In

Welcome ! Log into Your Account